Solubility was founded on IP licensing & commercialisation. As award winning leaders and certified experts in this field, we regularly provide legal assistance to large corporates, SMEs and venture backed businesses in structuring, drafting and negotiating IP commercialisation transactions.
We also regularly present seminars on licensing through our associations with the Melbourne University Masters of Laws program and the Licensing Executives Society of Australia and New Zealand.
How we can assist you:
- Develop a legally viable commercialisation strategy appropriate to your end goal
- Set up the legal structure appropriate to that goal
- Draft , review and negotiate relevant documents, including term sheets, option agreements, and licence agreements
- Prepare documentation for associated capital investment, including subscription, shareholder and escrow agreements.
- Settle any public announcement of the deal
- Manage the ongoing relationship with the other side
Recent case studies.
- Acting for Cynata Therapeutics Ltd (ASX: CYP), a listed Australian stem cell and regenerative medicine company, on a development and commercialisation partnership agreement in which Fujifilm Corporation, took an equity stake of $4m, and agreed to double digit royalties and potential future upfront and milestone payments in excess of $60m.
- Acting for Premneo Pharmaceuticals Pty Ltd, a new company established by Dr Brian McNamee (former CEO of CSL Limited) on drafting and negotiating in-licence agreement and related contracts for Premneo to license from Clover Corporation Limited a patent family owned by Clover and three patent families in-licensed by Clover from each of Cornell University, CSIRO and Women’s and Children’s Research Institute (Adelaide).
- Acting for St Vincent’s Institute in its collaborative partnership with Janssen Pharmaceuticals, Inc aimed at developing and commercialising small molecule modulators of microgial function and inflammation with the aim of reducing the amyloid plaque burden and Alzheimer’s disease severity.